Metagenomics Market is estimated to be valued at USD 200 million in 2021, It is growing at a CAGR of 17% over 2022-2028 to reach USD 600 million by 2027 due to a raise in funding from the public and private sectors for the development of metagenomics services. Moreover, the presence of skilled professionals focus on the research for metaproteomics, metatranscriptomics, and metabolomics services, the surge in demand for microbial screening in chemical and food industries, technological advancements in the biotechnology and bioinformatics tools, and sophisticated healthcare infrastructure are the major factors driving the growth of the metagenomics market. The global metagenomics market report gives a comprehensive outlook on metagenomics across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the global metagenomics market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the global metagenomics market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Through technological advancements, DNA sequencing platforms have made significant progress in recent years. They have a number of advantages over traditional methods, including lowering the number of pre-sequencing stages, ensuring sequence authenticity with lengthy reads (MB to GB) produced each run, and achieving high read precision. Advancements in this sector are expected to boost the market’s growth throughout the projected period, as DNA sequencing is closely linked to metagenomic investigations.